April 14, 2015 News by Patricia Silva, PhD New Novartis Analyses On Gilenya For Relapsing Multiple Sclerosis To Be Presented at Upcoming Conference NovartisĀ will present novelĀ GilenyaĀ data, demonstratingĀ the company’s methods for assessing the impact of relapsing multiple sclerosis (RMS) in bothĀ patients and physicians, during the 67th Annual Meeting of American Academy of Neurology (AAN) that will take place in Washington, DC between the 18th and the 25th of April, 2015. The data will…
April 13, 2015 News by Charles Moore Amarantus Advancing MSPrecise For Improved Diagnosis of Relapsing-Remitting MS Amarantus BioScience Holdings, Inc. (Amarantus) is a San Francisco based, development-stage, publicly-traded biotechnology company focused on discovering and developing first-in-class treatments and diagnostics in neurology for diseases associated with the dysfunction of a wide range of biological pathways, including protein misfolding, cell cycle dysregulation, neurodegeneration and apoptosis (Programmed Cell…
April 13, 2015 News by admin Biogen to Focus on RRMS Disease Management, Treatment at Upcoming Conference Biogen plans toĀ present new clinical data at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 ā 25, 2015, including numerous presentations focusing on multiple sclerosis. Ā In a company press release, Biogen statedĀ āAt AAN, we will feature new scientific data, including research highlighting the…
April 10, 2015 News by Patricia Silva, PhD MedDay To Release Phase III Clinical Trial Results for Experimental Progressive Multiple Sclerosis Therapy MedDayĀ recently announced in a news releaseĀ that it is preparing to release the design and results of its clinical trial to assess the safety and efficacy of MD1003 in primary and secondary progressive multiple sclerosis (MS) treatment. Data on the Phase III clinical trial (MS-SPI) will be presented…
April 9, 2015 News by Patricia Silva, PhD MS Patient Travels Abroad to Receive Stem Cell Treatment AĀ stem cell therapyĀ being administeredĀ to treat multiple sclerosis (MS) outside the United States was recently touted by an MSĀ patient who traveled to Mexico to receive the therapy, revealing significantĀ improvements in herĀ quality of life.Ā Debbie Bertrand, an MS patient who was diagnosed in 2001, is sharing her…
April 8, 2015 News by Patricia Silva, PhD National MS Society Announces $28 Million Funding For Research TheĀ National Multiple Sclerosis Society has announcedĀ it willĀ grantĀ $28 million to 84 new research projects and training awards focusedĀ on multiple sclerosis (MS). The new financial support is included in the society’s comprehensive research strategy, which was designed to not only endĀ MS, but also restore patients’…
April 8, 2015 News by Isaura Santos Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study A recent study suggests that in the futureĀ multiple sclerosis patients could benefit from treatments intendedĀ to boost their brain function. The study was published inĀ Nature NeuroscienceĀ and receivedĀ funding fromĀ The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…
April 8, 2015 News by Charles Moore MedDay Updates Status Of Pioneering Pivotal Phase III Study Design In Progressive Multiple Sclerosis MedDay, a Paris, France based biotechnology company specializing in treatment of neurological disorders, has released more information regarding the design of its (MS-SPI) clinical trial that is investigating the efficacy and safety of the investigational medicine MD1003 in treatment of primary and secondary progressive multiple sclerosis (MS). Progressive…
April 7, 2015 News by admin Wellness for People with MS Outlined in New Paper From the National MS Society The National Multiple Sclerosis (MS) Society recently released a recent paper on wellness titled “Wellness for People with MS: What do we know about Diet, Exercise and Mood And what do we still need to learn?“ The paper focuses on how wellness can be achieved by…
April 7, 2015 News by Patricia Silva, PhD Consortium of MS Centers Launches Mentorship Program The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) is launching aĀ new mentorship program dedicated to medical residents pursuing a neurology fellowship to accelerateĀ and support their work in treatingĀ multiple sclerosis (MS). The initiative was launched atĀ the beginning of the year and seeksĀ to provide information on career…
April 6, 2015 News by Patricia Silva, PhD Central Immune System Component Found to be Related to MS Neurodegeneration, Clinical Disability A recentĀ study published inĀ PLOS ONEĀ provides new insights into the relationship between the immune system and neurodegeneration and clinical disability in multiple sclerosis (MS). A team of researchers led by Dr.Ā Shahin Aeinehband from theĀ Neuroimmunology Unit at theĀ Karolinska Institutet in Sweden looked at the association between…
April 3, 2015 News by Maureen Newman Multiple Sclerosis Patients Less Susceptible to Gout in Study What do multiple sclerosis and gout have in common? Uric acid. Uric acid, a byproduct of purine metabolism, causes crystal accumulation in joints (usually in the foot) and subsequent pain. Uric acid has also been shown to protect neurons via antioxidant activity. Since high levels of uric acid that…
April 2, 2015 News by Patricia Silva, PhD Vaccinex Releases Pre-clinical Data on Experimental Multiple Sclerosis Therapy Vaccinex, Inc. recently announced positive resultsĀ for a multi center, randomized, double-blinded, placebo-controlled phase 1 clinical trial that evaluatedĀ single ascending-dose tolerability and safety inĀ an experimental treatment for Multiple Sclerosis (MS) adult patients. The researchers enrolled 50 MS patients in one of fiveĀ study groups (1, 3, 6, 10, and 20…
April 2, 2015 News by admin Can Exercise Improve MS-Related Cognitive Problems? Can exercise help brain function in people with multiple sclerosis (MS)? A new study suggests that it is possible. The reportĀ appeared in the Journal of Clinical and Experimental Neuropsychology. Led by Robert Motl inĀ theĀ Department of Kinesiology and Community Health at the University of Illinois at…
April 1, 2015 News by Patricia Silva, PhD Statins Therapy in Multiple Sclerosis Yields Controversial Results Researchers at the IRCCS Centro Neurolesi āBonino-Pulejoā and the University of Messina in Italy have performed a review on the immunomodulatory activity reported for statins in the treatment of multiple sclerosis (MS) and on clinical trial results. The study was published in the journal Pharmacological…
March 31, 2015 News by Patricia Silva, PhD MS Research Australia Funds Project on MS and Epstein-Barr Virus MS Research Australia has awardedĀ aĀ $150,000 grant to support a project being conducted atĀ Murdoch UniversityĀ aimed atĀ expanding scientific knowledge on the correlation between multiple sclerosis (MS) andĀ Epstein-Barr virus infection. The research grant was awarded to David Nolan, anĀ adjunct associate professor at the Institute of Immunology and Infectious Diseases (IIID),…
March 31, 2015 News by Patricia Silva, PhD New Clinical Study On Attention and Memory In People With MS A major trial to investigate different ways to deal with attention and memory problems in multiple sclerosis (MS) patients will take place atĀ Nottingham in the United Kingdom.Ā The Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis (CRAMMS)Ā study will focusĀ on these MS related symptoms…
March 30, 2015 News by Patricia Inacio, PhD New Purification Method Promises Affordable Antibody Production For Diseases Like MS The Austrian Centre of Industrial Biotechnology (acib) developed a new purification method for pharmaceutical produced antibodies that promises to effectively decrease the high prices of these drugs in the market. Therapeutic antibodies revolutionized how doctorsĀ treat diseases affecting a large number of individuals, such as cancer and autoimmune…
March 27, 2015 News by Maureen Newman New Imaging Technique Reveals MS Progression Related to Diffusivity in Brain Scientists are developing new tools to understand multiple sclerosis pathogenesis and monitor the benefits of treatments. One of these tools is diffusion tensor imaging (DTI), a novel techniqueĀ that describes the microstructural organization of white matter tracts in the brain. Although DTI has greater pathological specificity than magnetic resonance imaging…
March 26, 2015 News by admin MS Treatment Using Stem Cells Shows Promise Compared to Medication New researchĀ from Italy and SpainĀ demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better thanĀ the medicationĀ mitoxantrone in treating severe cases of multiple sclerosis.Ā The studyĀ appearedĀ in the February 11, 2015, online issue of Neurology. Ā MS is characterized by an immune system attack on the…
March 26, 2015 News by Patricia Silva, PhD Online Neurology Resource Platform Launches Recent MS Research Findings The online community for neurologists Neurology TimesĀ will feature special coverage focused on multiple sclerosis (MS) in celebration ofĀ MS Awareness Month, which is currently taking place in March. The online platform was designed to provide healthcare professionals with informational resources about several hard…
March 24, 2015 News by Patricia Silva, PhD Researchers Develop First Accurate Method to Assess Important Protein in MS, Other Diseases Researchers at the University of Copenhagen and Rigshospitalet in Denmark have for the first time developed an accurate method to measure apolipoprotein M (apoM), a protein thatĀ is involved in several diseases like diabetes but also arteriosclerosis and sclerosis, disorders characterized by the stiffening of structures usually by…
March 23, 2015 News by admin MS Progression May Be Stopped By New Anti-inflammatory Molecule Researchers at theĀ Walter and Eliza Hall Institute, the oldest research center in Australia, developed a molecule that may quellĀ inflammation and stop the progression of multiple sclerosis (MS). The molecule couldĀ eventually be used as a drug for the disease. MSĀ is an inflammatory autoimmune diseaseĀ in which the body attacks…
March 20, 2015 News by Kara Elam New MS Educational Program Seeks to Improve Care in Women This week the Consortium of Multiple Sclerosis Centers (CMSC) in collaboration with The France Foundation, a provider of continuing medical education have launched a new educational program focused on the important issues that affect women with multiple sclerosis (MS), entitled, āStrategies to Improve the…
March 19, 2015 News by Patricia Silva, PhD Multiple Sclerosis Eye Care Center Commemorates 10-Year Anniversary TheĀ Multiple Sclerosis Eye Center for Analysis, Research and Education (MS Eye CARE) is celebrating 10 years of expertĀ eye care in improvingĀ diagnosis and treatment of multiple sclerosis (MS). The Center isĀ the result of aĀ collaboration betweenĀ theĀ University Eye Institute at the University of Houstonās College of Optometry and the…
March 18, 2015 News by admin MS Patients Weigh In on Physician Conflicts of Interest in New Study Multiple sclerosis (MS) is difficult enough for those who have it, causing damage to the nervous system, difficulty with movement, sensation, numbness, loss of vision and pain. People with MS rely on medications and the care of physicians to manage their symptoms and the progressions of the disease. But…
March 17, 2015 News by Patricia Silva, PhD Hypertension Medication Found to Offer Protective Effect Against Multiple Sclerosis Symptoms in Mice A new study recently published in the journal Nature CommunicationsĀ led by researchers at The University of ChicagoĀ revealed that a drug for hypertension has a protective effect against symptoms characteristic of multiple sclerosis (MS) in mouse models. The study is entitled āPharmaceutical integrated…
March 16, 2015 News by admin Can Emotional Health Influence MS Treatment Outcomes? Emotional health is important when battling any illness, including multiple sclerosis (MS). Despite this, sometimes the benefits of emotional health are overlooked by healthcare providers. Excessive stress can lead to anxiety and depression, which increases hormones such as adrenalin and glucocorticoids that shut down the immune system. Glucocorticoids have…
March 13, 2015 News by admin Two Progressive MS Phase III Trials to be Presented at AAN Annual Meeting Myelin — the fatty substance that wraps around nerve cells — is lost in multiple sclerosis (MS). Is there any way to get it back or to stop the deterioration of myelin? Researchers at MedDay Pharmaceuticals think that their drug may provide the solution. Known asĀ MD1003, the…
March 12, 2015 News by admin Novel Switch for Autoimmune Diseases Could Play Role In MS National Institutes of Health (NIH) scientists may have discovered a critical immune system switch that could affect genes involved in autoimmune diseases.Ā The ground-breaking work, published in the journalĀ Nature,Ā may be useful for developing treatments forĀ autoimmune disorders such as multiple sclerosis (MS). MS is characterized by an immune system…